ProCE Banner Activity

Frequently Asked Questions About Addressing Social Determinants of Health in NVAF

Clinical Thought

Expert faculty answer key questions posed during a live webinar addressing social determinants of health in nonvalvular atrial fibrillation (NVAF).

Released: May 26, 2022

Expiration: May 25, 2023

Share

Faculty

Keith C. Ferdinand

Keith C. Ferdinand, MD, FACC, FAHA

Professor of Medicine
Tulane Heart and Vascular Institute
Tulane University School of Medicine
New Orleans, Louisiana

David S. Kountz

David S. Kountz, MD

Professor of Medicine
Department of Medicine
Hackensack Meridian School of Medicine
Nutley, New Jersey

Laura Ross

Laura Ross, PA-C, CLS

Physician Assistant
Clinical Lipid Specialist

Park Nicollet Heart and Vascular Center
Methodist Hospital
St Louis Park, Minnesota

Provided by

Provided by Clinical Care Options and Practicing Clinicians Exchange.

ProCE Banner
ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Pfizer Alliance

Partners

APAC

ProCE Banner

Program Director Disclosure

Program Director

Keith C. Ferdinand, MD, FACC, FAHA

Professor of Medicine
Tulane Heart and Vascular Institute
Tulane University School of Medicine
New Orleans, Louisiana

Keith C. Ferdinand, MD, FACC, FAHA, has disclosed that he has received consulting fees from Amgen, Boehringer Ingelheim, Medtronic, Novartis, and Sanofi.

Faculty Disclosure

Primary Author

David S. Kountz, MD

Professor of Medicine
Department of Medicine
Hackensack Meridian School of Medicine
Nutley, New Jersey

David S. Kountz, MD, has no relevant conflicts of interest to report.

Laura Ross, PA-C, CLS

Physician Assistant
Clinical Lipid Specialist

Park Nicollet Heart and Vascular Center
Methodist Hospital
St Louis Park, Minnesota

Laura Ross, PA-C, CLS, has no relevant conflicts of interest to report.